Flexion Therapeutics, Inc. stock price

Flexion Therapeutics, Inc. latest news:


  • 12/13/2017 14:11:47

    BRIEF-Flexion Therapeutics Acquires Rights To Genequine Biotherapeutics' Non-Opioid Drug

    Flexion Therapeutics Inc(FLXN): * FLEXION THERAPEUTICS ANNOUNCES ACQUISITION OF NOVEL, NON-OPIOID ASSET FOR OSTEOARTHRITIS OF THE KNEE. * Flexion Therapeutics Inc(FLXN) - ENTERED INTO A DEFINITIVE AGREEMENT WITH GENEQUINE BIOTHERAPEUTICS GMBH TO ACQUIRE GLOBAL RIGHTS TO GQ-20.

  • 12/11/2017 15:31:40

    BRIEF-Flexion Therapeutics Announces Appointment Of Scott Kelley, M.D. As Chief Medical Officer

    Flexion Therapeutics Inc(FLXN): * FLEXION THERAPEUTICS ANNOUNCES APPOINTMENT OF SCOTT KELLEY, M.D. AS CHIEF MEDICAL OFFICER Source text for Eikon: Further company coverage:

  • More trends:

    FlexShares Credit-Scored US Corporate Bond Index FSKOR | FlexShares Disciplined Duration MBS Index FundMBSD | Flexsteel Industries, Inc.FLXS | Flextronics International Ltd.FLEX | FLIR Systems, Inc.FLIR | Fluidigm CorporationFLDM | Flushing Financial CorporationFFIC | Foamix Pharmaceuticals Ltd.FOMX | Fogo de Chao, Inc.FOGO | Fonar CorporationFONR |